SG Tylor
Vaginal Cancer: A Comprehensive Guide to Symptoms, Types, Causes, Treatment and More
Vaginal cancer is a rare but serious condition that affects the muscular tube that connects your uterus with your outer ...
How Skyrizi Outspent Other Drugs in a Tough Market
In July, AbbVie’s Skyrizi maintained its position as the top pharma drug ad spender for the second consecutive month, but ...
Lilly’s Retevmo Outperforms Gavreto in Lung Cancer Study
Source – Eli Lilly In the ongoing rivalry between Eli Lilly and Blueprint Medicines over their RET inhibitors, Eli Lilly ...
Galapagos Drops Jyseleca in Europe, Lowers Sales Outlook
Galapagos has suffered a significant setback as it decided not to submit a Marketing Authorization Application (MAA) for its drug ...
FDA Approves Zurzuvae: A Game-Changer for Postpartum
Source – Biogen Biogen and Sage Therapeutics have received FDA approval for Zurzuvae (zuranolone) 50 mg, a breakthrough treatment for ...
FDA Approves Izervay for Geographic Atrophy
Source – Astellas Pharma Astellas Pharma has received FDA approval for Izervay (avacincaptad pegol intravitreal solution) for the treatment of geographic ...
Gilead’s $3B Oncology Milestone: Trodelvy, Tecartus and Yescarta Lead the Way in 2023
Gilead Sciences has been making significant strides in the oncology space, fueled by the success of its rising star drug, ...
Tornado Wreaks Havoc on Pfizer’s Rocky Mount Plant, Causes Drug Shortages
Amid concerns of potential supply shortages of critical hospital drugs, Pfizer has taken precautionary measures in response to the tornado ...
Gilteritinib and Allo HSCT Together Increase Survival in FLT3-Mutated AML
Results from a real-world study presented at the European Society for Blood and Marrow Transplantation (EBMT) 49th Annual Meeting indicate ...
ABM-1310 receives Orphan Drug Designation from the FDA for Glioblastoma
Source – ABM Therapeutics ABM Therapeutics has received orphan drug designation from the FDA for ABM-1310, a novel small molecule ...
Marrazzo will follow Fauci as director of NIAID
After extensive deliberations, the National Institute of Allergy and Infectious Diseases (NIAID) has appointed a new director to succeed Dr. ...
PacBio to Acquire Apton Biosystems for Next-Gen Short-Read Sequencer Development
Source – PacBio Gene sequencing specialist PacBio has signed an agreement to acquire Apton Biosystems, a move that will enhance ...
The legacy of Bristol Myers and BeiGene Celgene’s payment comes years after China’s prohibition
In 2020, an unexpected manufacturing issue led to a ban on the import of Bristol Myers Squibb’s (BMS) Abraxane, distributed ...
CDMO Experiences Downturn at Merck KGaA as COVID-Related Sales Plunge, Says CFO
Merck KGaA is facing the challenges it anticipated for 2023, with its contract manufacturing division and process solutions arm experiencing ...
Moderna finds promise in the private COVID vaccination market and the debut of RSV as sales plummet
Source – Fiercepharma As Moderna continues its operations beyond the pandemic, the biotech firm has increased its revenue projection for ...
To restock the US with smallpox and mpox vaccines, Bavarian Nordic signs a $120 million BARDA contract
Source – Bavarian Nordic Vaccine manufacturer Bavarian Nordic, which played a crucial role in combating the mpox outbreak in 2022, ...
A user of well-known GLP-1 medications has filed a lawsuit against Novo Nordisk and Eli Lilly
As Novo Nordisk and Eli Lilly enjoy significant sales from their GLP-1 diabetes and obesity drugs, they also face legal ...
Merck’s Ervebo has received US FDA approval for use in children 12 months of age and older
Source – Merck Merck announced that the US Food and Drug Administration (FDA) has granted expanded approval for Ervebo. The ...
Understanding Urethral Cancer: Causes, Symptoms, Diagnosis, Treatment, And Prognosis
Introduction Of Urethral Cancer Urethral cancer is a rare type of cancer that affects the urethra, the tube that carries ...
Karyopharm reduces employees by 20% as Xpovio sales for blood cancer remain stagnant
Source – Karyopharm Therapeutics Karyopharm Therapeutics, faced with stagnant sales of its only approved product, Xpovio (selinexor), has announced a ...
Samsung wants to describe its Humira biosimilar as “interchangeable.”
While several biosimilars of AbbVie’s top-selling drug, Humira, are already available in the US market, only one, Boehringer Ingelheim’s Cyltezo, ...
With Austedo running and the Uzedy launch underway, Teva is beginning to show indications of improvement
With a fresh growth strategy in place and two successful recent launches, Teva seems to be stepping into a new ...
Teva sets aside $200 million in ‘advanced’ settlement negotiations to end the US price-fixing investigation
Teva, a pharmaceutical company facing a price-fixing indictment by the U.S. Department of Justice (DOJ), is taking steps to resolve ...
GSK files a patent infringement lawsuit against Pfizer as the RSV vaccination war begins
In the latest vaccine showdown, GSK and Pfizer are engaged in a legal battle over patent infringement claims. GSK alleges ...
Is Biogen giving up its biosims business to Samsung Bioepis?
During the first-quarter earnings call, CEO Chris Viehbacher discussed his plan to revitalize Biogen and emphasized the need to find ...
Checkpoint inhibitor patent challenges are settled by AZ and BMS
AstraZeneca has announced the resolution of three lawsuits filed against it by Bristol-Myers Squibb (BMS) and Ono Pharma, alleging patent ...
Endometrial Cancer Patients Get New Option with Jemperli
Source – GSK GSK has secured approval from the US for Jemperli, in combination with chemotherapy, as a first-line treatment ...
Despite CSL’s hemophilia B gene therapy, NICE is not persuaded
The UK’s National Institute for Health and Care Excellence (NICE) has expressed hesitation in recommending approval for CSL Behring and ...
Lonsurf gets a boost from FDA for colorectal cancer, challenging rivals Takeda and Hutchmed
Source – Taiho Oncology Eight years after initially gaining FDA approval for the treatment of heavily pretreated colorectal cancer, Taiho ...
IVS-3001 been given Fast Track Designation by the FDA for RCC
The FDA has granted fast track designation (FTD) to IVS-3001, an innovative chimeric antigen receptor (CAR) T-cell therapy, intended for ...
